These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28757151)

  • 21. Internet seen as clinical research tool.
    Mitka M
    JAMA; 2005 Nov; 294(18):2290-1. PubMed ID: 16278350
    [No Abstract]   [Full Text] [Related]  

  • 22. 2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
    Dickstein K; Vardas PE; Auricchio A; Daubert JC; Linde C; McMurray J; Ponikowski P; Priori SG; Sutton R; van Veldhuisen DJ; ;
    Eur J Heart Fail; 2010 Nov; 12(11):1143-53. PubMed ID: 20965877
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomization. Part 2: Minimization.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2011 Dec; 140(6):902-4. PubMed ID: 22133958
    [No Abstract]   [Full Text] [Related]  

  • 24. Potential bias in "controls" used in a heart failure disease-management program.
    Wilson T; Linden A
    J Am Geriatr Soc; 2005 Jul; 53(7):1268-9. PubMed ID: 16108960
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiac contractility modulation: the next cardiac resynchronization therapy or another renal sympathetic denervation?
    Mentz RJ; Butler J
    J Card Fail; 2015 Jan; 21(1):24-6. PubMed ID: 25463742
    [No Abstract]   [Full Text] [Related]  

  • 26. The tactics of large randomized trials.
    Slobogean GP; Sprague S; Bhandari M
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():19-23. PubMed ID: 22810442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practical issues in conducting clinical trials: randomized, controlled trials of imaging studies.
    Jarvik JG
    Acad Radiol; 1998 Sep; 5 Suppl 2():S266-8. PubMed ID: 9750828
    [No Abstract]   [Full Text] [Related]  

  • 28. Run-in periods in randomized trials: implications for the application of results in clinical practice.
    Pablos-Méndez A; Barr RG; Shea S
    JAMA; 1998 Jan; 279(3):222-5. PubMed ID: 9438743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The EMPHASIS-HF study].
    Boccanelli A; Agostoni P
    G Ital Cardiol (Rome); 2011 May; 12(5):315-8. PubMed ID: 21593949
    [No Abstract]   [Full Text] [Related]  

  • 30. Monitoring clinical trials. Several points are contentious.
    Parry D
    BMJ; 2001 Dec; 323(7326):1425. PubMed ID: 11778590
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cluster randomised trials].
    Caille A; Leyrat C; Giraudeau B
    Ann Dermatol Venereol; 2014 Feb; 141(2):144-6. PubMed ID: 24507210
    [No Abstract]   [Full Text] [Related]  

  • 32. Surgical ventricular reconstruction.
    Ghali JK
    N Engl J Med; 2009 Jul; 361(5):529; author reply 531-2. PubMed ID: 19641213
    [No Abstract]   [Full Text] [Related]  

  • 33. The darker side of randomized trials: recruitment challenges.
    Sibai T; Carlisle H; Tornetta P
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():49-55. PubMed ID: 22810448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging designs in orthopaedics: expertise-based randomized controlled trials.
    Scholtes VA; Nijman TH; van Beers L; Devereaux PJ; Poolman RW
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():24-8. PubMed ID: 22810443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
    Gheorghiade M; Gattis WA; Adams KF; Jaffe AS; O'Connor CM; ;
    Am Heart J; 2003 Feb; 145(2 Suppl):S55-7. PubMed ID: 12594453
    [No Abstract]   [Full Text] [Related]  

  • 36. Lessons to be learnt from unsuccessful clinical trials.
    Smyth RL
    Thorax; 2011 Jun; 66(6):459-60. PubMed ID: 21429900
    [No Abstract]   [Full Text] [Related]  

  • 37. The importance of considering the effects of perceived group assignment in placebo-controlled trials.
    Benedetti F
    Eval Health Prof; 2005 Mar; 28(1):5-6. PubMed ID: 15677382
    [No Abstract]   [Full Text] [Related]  

  • 38. Critical factors for credibility in clinical trials: Comments on Aickin's "Beyond randomization".
    Walach H
    J Altern Complement Med; 2002 Dec; 8(6):773-5. PubMed ID: 12614530
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of Run-in Periods in Randomized Trials.
    Huo X; Armitage J
    JAMA; 2020 Jul; 324(2):188-189. PubMed ID: 32662850
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cardiac resynchronization therapy in chronic heart failure].
    Sticherling C
    Praxis (Bern 1994); 2007 Mar; 96(11):421-2. PubMed ID: 17405535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.